Navivumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Navivumab Usage And Synthesis

Uses

Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2[1].

References

[1] Beigel JH. Polyclonal and monoclonal antibodies for the treatment of influenza. Curr Opin Infect Dis. 2018 Dec;31(6):527-534. DOI:10.1097/QCO.0000000000000499

Navivumab(1443004-16-7)Related Product Information

• Rosmantuzumab
• Cendakimab
• Gresonitamab
• Anrukinzumab
• Tibulizumab
• Lusvertikimab
• Talacotuzumab
• Ivicentamab
• Flanvotumab
• Firivumab